Keywords: LC; liquid chromatography; MS; mass spectrometry; MS/MS; tandem mass spectrometry; UPLC; ultra-high-performance liquid chromatography; MRM; multiple reaction monitoring; ESCC; esophageal squamous cell carcinoma; LC-MS; liquid chromatography-mass spectrome
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: CI; confidence interval; c-index; Harrell's concordance index; EC; Esophageal cancer; ESCC; esophageal squamous cell carcinoma; FP; 5-FU plus platinum; HR; hazard ratio; IR; irregular regimen; NLR; neutrophil to lymphocyte ratio; OS; overall survival; PLR
Keywords: ESCC; esophageal squamous cell carcinoma; 2D LC-MS; two-dimensional liquid chromatography-mass spectrometry; FFA; free fat acids; PC; phosphatidylcholines; Chok; choline kinase; ESI; electrospray ionization; PCA; principal component analysis; PLS-DA; pa
Keywords: CT; computed tomography; CRT; chemoradiotherapy; DSS; disease-specific survival; ESCC; esophageal squamous cell carcinoma; ESD; endoscopic submucosal dissection; LRFS; local relapse-free survival; OS; overall survival; PDT; photodynamic therapy; RT; radio
Keywords: Krüppel-like factor 4; Meta-analysis; Prognosis; Cancer; Tumor; Carcinoma; TNBC; triple-negative breast cancer; BC; breast cancer; CRC; colorectal cancer; ESCC; esophageal squamous cell carcinoma; GC; gastric cancer; HCC; hepatocellular carcinoma; NPC; n
Keywords: Microtubule destabilizing agents; Esophageal squamous cell carcinoma; Antitumor effect; Apoptosis; Vascular disrupting agents; AC-α-tubulin; acetylated-α-tubulin; CA4; combretastatin A-4; DAPI; 6-diamidino-2-phenylindole; ESCC; esophageal squamous cell
Keywords: HNE; 4-hydroxynonenal; NMR; nuclear magnetic resonance; MS; mass spectrometry; LC-MS; liquid chromatography-mass spectrometry; GC-MS; gas chromatography-mass spectrometry; CE-MS; capillary electrophoresis-mass spectrometry; MALDI-IMS; matrix-assisted lase
Keywords: Essential Trace Elements; Dietary Intake; Esophageal Cancer; Dose-Response; Meta-Analysis; BMI; body mass index; CI; confidence interval; DHQ; Dietary History Questionnaire; EAC; esophageal adenocarcinoma; ESCC; esophageal squamous cell cancer; FFQ; Foo
Keywords: Esophageal Cancer; Squamous Cell Carcinoma; Epidemiology; Genetic Epidemiology; BMI; body mass index; EADC; esophageal adenocarcinoma; ESCC; esophageal squamous cell carcinoma; GWAS; genome-wide association studies; IARC; International Agency for Researc
Keywords: DCM; disulfide crosslinked-micelle; DTX; docetaxel; ESCC; Esophageal squamous cell carcinoma; IHC; immunohistochemistry; TEM; Transmission electron microscope; DLS; dynamic light scatting; CI; combination index; Fa; Fraction affected; FBS; Feutal bovine s
Keywords: Tumor; Esophageal Neoplasm; Inflammation; Screening; ACG; American College of Gastroenterology; BE; Barrett's esophagus; EA; esophageal atresia; EAC; esophageal adenocarcinoma; ESCC; esophageal squamous cell carcinoma; GEJ; gastroesophageal junction/gas
Keywords: Esophageal Cancer; Genomics; Epigenomics; ADAR; adenosine deaminases acting on RNA; APOBEC; apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like; BCH; basal cell hyperplasia; CIS; carcinoma in situ; CNA; copy number alteration; ESCC; esophagea
Keywords: Esophageal Cancer; Imaging; Early Detection; Accuracy; CIS; carcinoma in situ; ESCC; esophageal squamous cell carcinoma; ESD; esophageal squamous dysplasia; ESECC; esophageal cancer screening in China; EVL; endoscopically visualized lesion; NEVL; not endo
Keywords: DSS; disease-specific survival; ESCC; esophageal squamous cell carcinomas; ESD; endoscopic submucosal dissection; HR; hazard ratio; LNM; lymph node metastasis; LVI; lymphovascular invasion; M1; invasion limited to the intraepithelium; M2; invasion limited
Keywords: Geriatric nutritional risk index; Nutritional risk index; Body mass index; Esophageal cancer; Prognosis; Squamous cell carcinoma; Chemordiation therapy; Geriatric Nutritional Risk Index; GNRI; Esophageal squamous cell carcinoma; ESCC; Unio Internationalis
Keywords: AUC; area under the ROC curve; CCA; cholangiocarcinoma; EAC; esophageal adenocarcinoma; ESCC; Esophageal squamous cell carcinoma; FDA; US Food and Drug Administration; FIT; fecal immunochemical test; FOBT; fecal occult blood test; GI; gastrointestinal; HC
Keywords: BE; Barrett's esophagus; ESCC; esophageal squamous cell carcinoma; FICE; Fuji intelligent chromoendoscopy; HRME; high-resolution microendoscopy; MDM; methylated DNA marker; NBI; narrow-band imaging; SOS; Sponge on a String; TNE; transnasal endoscopy; WL
Keywords: Oxysterols; Cancer; Polymorphism; Risk; Genetics; Cholesterol; 25(OH)D; 25-hydroxyvitamin D; ABC; ATP-binding cassette; AEBS; antiestrogen-binding site; BC; breast cancer; BCR; biochemical recurrence; CETP; cholesteryl ester transfer protein; CH25H; chole
Keywords: LAMP1; lysosomal associated membrane protein 1; ESCC; esophageal squamous cell carcinoma; IHC; immunohistochemistry; TMAs; tissue microarrays; Lysosomal associated membrane protein 1; Histological differentiation; Immunohistochemistry; Esophageal tumor;
Keywords: AC; adenocarcinoma; ARCON; accelerated radiotherapy with carbogen breathing and nicotinamide; CA IX; carbonic anhydrase; CCRT; concurrent chemoradiotherapy; CR; complete response; Cu-ATSM,; copper-62 labeled diacetyl-bis (N4-methylthiosemicarbazone); DFS;
Keywords: Predictive biomarkers; Pathology response; Esophageal cancer; Chemo(radio)therapy; Meta-analysis; ESCC; Esophageal squamous cell carcinoma; AC; Adenocarcinoma; TS; Thymidylate synthase; Bax; Bcl-2-associated X protein; Bcl-2; B-cell lymphoma 2; CYFRA21-1;
Keywords: Cancer Screening; Risk Stratification; Cost Effectiveness; Individualized Assessment; AIC; Akaike information criterion; AUC; area under the curve; BMI; body mass index; CI; confidence interval; CIS; carcinoma in situ; ESCC; esophageal squamous cell carci
Keywords: ESCC; esophageal squamous cell carcinoma; ESD; endoscopic submucosal dissection; POEM; per-oral endoscopic myotomy;
Keywords: Esophagus; Sequencing; Carcinogenesis; Driver Mutation; APOBEC; apolipoprotein B messenger RNA editing enzyme, catalytic polypeptide-like; CNA; copy number alteration; EAC; esophageal adenocarcinoma; ESCC; esophageal squamous cell carcinoma; ESSH; esophag
Keywords: Microorganism; Gastrointestinal carcinoma; Tumor location; CagA; cytotoxin-associated gene A; CIMP; CpG island methylator phenotype; EAC; esophageal adenocarcinoma; ESCC; esophageal squamous cell carcinoma; MSI; microsatellite instability; NOD; nucleotide
Keywords: Local control; Spine radiosurgery; Spine surgery; Tumor; Wound infection; CT; Computed tomography; CTV; Clinical target volume; DRR; Digitally reconstructed radiograph; ESCC; Epidural spinal cord compression; IM; Infrared markers; MESCC; Metastatic epidur
Keywords: CI; confidence interval; CT; computed tomography; EC; esophageal cancer; ESCC; esophageal squamous cell carcinoma; OR; odds ratio; PET; positron emission tomography; RLN; regional lymph node; RLNR; regional lymph node recurrence; SYSUCC; Sun Yat-sen Unive
Keywords: EC; esophageal cancer; EADC; esophageal adenocarcinoma; ESCC; esophageal squamous cell carcinoma; DMET; drug metabolism enzymes and transporters; ROC; receiver operating characteristics; AUC; area under the curve; RECIST; response evaluation criteria in s
Keywords: CI; confidence interval; CRT; chemoradiotherapy; EPS; esophagus-preserved survival; ESCC; esophageal squamous cell carcinoma; HR; hazard ratio; OS; overall survival; PDT; photodynamic therapy; PFS; progression-free survival;
Keywords: HMG-CoA; Pleiotropy; Esophagus; CPRD; BMI; body mass index; CI; confidence interval; DDD; defined-daily dose; EAC; esophageal adenocarcinoma; EC; esophageal cancer; EGJA; esophagogastric junctional adenocarcinoma; ESCC; esophageal squamous cell carcinoma;
Keywords: BAMBI; BMP and activin membrane-bound inhibitor; CCM; conditioned cell medium; CCL4; C-C motif chemokine ligand 4; CCL28; C-C motif chemokine ligand 28; CXCL3; C-X-C motif chemokine ligand 3; DAP; 1,5-diaminopentane; ESCC; esophageal squamous cell carcino
Keywords: AUC; area under the curve; ESCC; esophageal squamous cell carcinoma; ESCN; esophageal squamous cell neoplasia; HRME; high-resolution microendoscopy; LCE; Lugol's chromoendoscopy; ROI; region of interest;
Keywords: AJCC; American Joint Committee on Cancer; ESCC; esophageal squamous cell carcinoma; HR; hazard ratio; NDLN; negative dissected lymph nodes; PDLN; positive dissected lymph nodes; PRDLN; positive rate of dissected lymph nodes; RLND; radical lymph node disse
Keywords: cTis; Clinical Trials Information System; cTNM; clinical tumor-node-metastasis; ESCC; esophageal squamous cell carcinoma; MIE; minimally invasive esophagectomy; OE; open esophagectomy; pTNM; pathologic tumor-node-metastasis; QOL; quality of life; 7; 8.7;
Keywords: ESCC; TAAs; Autoantibodies; mSERPA; HSP105; TIM
Keywords: Esophagus; Tumor; Squamous Cell Carcinoma; HMG-CoA; BMI; body mass index; CI; confidence interval; EAC; esophageal adenocarcinoma; EC; esophageal carcinoma; EGJA; esophagogastric junctional adenocarcinoma; ESCC; esophageal squamous cell carcinoma; GERD; g
Keywords: CI; confidence interval; EAC; esophageal adenocarcinoma; EC; esophageal cancer; EET; endoscopic eradication therapy; ESCC; esophageal squamous cell carcinoma; HR; hazard ratio; SEER; Surveillance, Epidemiology, and End Results;
Keywords: Esophageal Cancer; Etiology; Risk Factors; Sex Differences; BE; Barrett's esophagus; BEACON; Barrett's and Esophageal Adenocarcinoma Consortium; BMI; body mass index; CI; confidence interval; EAC; esophageal adenocarcinoma; ESCC; esophageal squamous cell
MicroRNA-30c functions as a tumor suppressor via targeting SNAI1 in esophageal squamous cell carcinoma
Keywords: ESCC; miR-30c; EMT;
The prognostic value of high LncRNA AFAP1-AS1 expression in various cancers: A systematic review and meta-analysis containing 21 studies
Keywords: LncRNA AFAP1-AS1; Cancer; Prognostic; Clinicopathological, meta-analysis; OS; overall survival; PFS; progression-free survival; DFS; disease-free survival; RFS; relapse free survival; CP; clinical parameters; NSCLC; non-small cell lung cancer; PDAC; pancr
Osthole inhibits the PI3K/AKT signaling pathway via activation of PTEN and induces cell cycle arrest and apoptosis in esophageal squamous cell carcinoma
Keywords: ESCC; Osthole; Cell cycle; Apoptosis; PTEN; PI3K/AKT;
Neutrophil to Lymphocyte Ratio as Predictor of Treatment Response in Esophageal Squamous Cell Cancer
Keywords: cCR; clinical complete response; ÎNLR; difference in neutrophil to lymphocyte ratio; DFS; disease-free survival; ESCC; esophageal squamous cell carcinoma; IQR; interquartile range; NLR; neutrophil to lymphocyte ratio; pCR; pathologic complete response; Q
Functions and mechanisms of microRNA-31 in human cancers
Keywords: 3â²-UTRs3â²; -untranslated regions; ADC; Adenocarcinoma; BC; Breast cancer; BER; base excision repair; CDK4; cyclin-dependent kinase 4; CRC; Colorectal cancer; CRT; chemo-radiation therapy; C-TAD; COOH terminal transactivation domain; DHR1; dihydrorhoda
Cancer epidemiology fieldwork in a resource-limited setting: Experience from the western Kenya ESCCAPE esophageal cancer case-control pilot study
Keywords: AMPATH; Academic Model Providing Access to Healthcare; EC; esophageal cancer; EGD; esophago-gastro-duodenoscopy; ESCC; esophageal squamous cell carcinoma; LMIC; low-middle income country; MTRH; Moi Teaching and Referral Hospital; Case-control study; Esoph
Serum anti-TOPO48 autoantibody as a biomarker for early diagnosis and prognosis in patients with esophageal squamous cell carcinoma
Keywords: ESCC; TOPO48; Anti-TOPO48 autoantibodies; Early diagnosis; Prognosis;
Prognostic significance of STIP1 expression in human cancer: A meta-analysis
Keywords: Stress-induced protein 1; Overall survival; Disease-free survival; Cancer; Prognosis; Meta-analysis; STIP1; stress-induced protein 1; HSP; heat shock protein; TPR; tetratricopeptide repeat; PRISMA; Preferred Reporting Items for Systematic reviews and Meta
LINC00657 played oncogenic roles in esophageal squamous cell carcinoma by targeting miR-615-3p and JunB
Keywords: ESCC; esophageal squamous cell carcinoma; SEER; Surveillance, Epidemiology, and End Results Program; TCGA; the cancer genome atlas; NORAD; Noncoding RNA Activated by DNA Damage; LINCRNA; long intergenic non-coding RNA; ceRNA; competing endogenous RNA; MTT
Targeting c-Myc: JQ1 as a promising option for c-Myc-amplified esophageal squamous cell carcinoma
Keywords: Esophageal squamous cell carcinoma; Targeting c-Myc; JQ1; c-Myc amplification; Patient derived xenograft; ESCC; esophageal squamous cell carcinoma; BET; bromodomain and extra-terminal; IC 50; the half maximal inhibitory concentration; NGS; Next-Generation
MiR-214 promotes cell meastasis and inhibites apoptosis of esophageal squamous cell carcinoma via PI3K/AKT/mTOR signaling pathway
Keywords: MiR-214; Meastasis; Apoptosis; PI3K/AKT/mTOR pathway; ESCC;
Up-regulated miR-548k promotes esophageal squamous cell carcinoma progression via targeting long noncoding RNA-LET
Keywords: ESCC; esophageal squamous cell carcinoma; lncRNA; long noncoding RNA; miRNA; microRNA; HCC; hepatocellular carcinoma; qPCR; quantitative polymerase chain reaction; NC; negative control; EdU; Ethynyl deoxyuridine; WT; wild type; NF90; nuclear factor 90; Mi